BioStrand (a subsidiary of IPA) – Medium

BioStrand (a subsidiary of IPA)

Pinned

BioStrand (a subsidiary of IPA)

Multimodal language models in protein engineering: Functional clonotyping & beyond

In the beginning of 2023, ChatGPT achieved a significant milestone of 100 million users. The utilization of generative AI defined the year…

Feb 1

Multimodal language models in protein engineering: Functional clonotyping & beyond

Feb 1

Pinned

BioStrand (a subsidiary of IPA)

Explained: how to plot the prediction quality metrics with AlphaFold2

In a previous blog post , we discussed the importance of AlphaFold2 (as well as other, deep-learning based methods) to accelerate the…

Jan 9, 2023

Explained: how to plot the prediction quality metrics with AlphaFold2

Jan 9, 2023

BioStrand (a subsidiary of IPA)

Transforming drug design: Vector search in text analysis

AI-Driven Rational Drug Design is central to BioStrand’s mission to power the intersection of biotech discovery, biotherapeutics and AI…

Jun 13

Transforming drug design: Vector search in text analysis

Jun 13

BioStrand (a subsidiary of IPA)

High-throughput in silico epitope binning, with in vitro grade accuracy

Efficient, scalable antibody drug discovery and development is grounded in the high-throughput isolation of substantial quantities of…

May 30

High throughput in silico epitope binning with in vitro grade accuracy

May 30

BioStrand (a subsidiary of IPA)

Epitope binning explained: A powerful tool for antibody development

Epitope-based screening approaches are playing a pivotal role in the development of modern antibody therapies for various diseases…

May 7

Epitope binning explained: A powerful tool for antibody development

May 7

BioStrand (a subsidiary of IPA)

Private Conda package servers: Choosing the right solution

If you are a newcomer to the Python ecosystem, it can be daunting to know how to setup your python environment. There are tens of…

Apr 9

Private Conda package servers: Choosing the right solution

Apr 9

BioStrand (a subsidiary of IPA)

Generative AI in drug discovery

Following a breakout year of rapid growth, generative AI has been widely, and justifiably, described as an undisputed game-changer for…

Feb 20

Generative AI in drug discovery

Feb 20

BioStrand (a subsidiary of IPA)

Biomedical knowledge graphs and the power of ontology

Knowledge graphs play a crucial role in the organization, integration, and interpretation of vast volumes of heterogeneous life sciences…

Jan 23

Biomedical knowledge graphs and the power of ontology

Jan 23

BioStrand (a subsidiary of IPA)

Mitigating LLM Hallucinations

However, there are still several challenges that have to be addressed before LLMs can be reliably integrated into in-silico drug discovery…

Jan 9

Mitigating LLM Hallucinations

Jan 9

BioStrand (a subsidiary of IPA)

How retrieval-augmented generation (RAG) can transform drug discovery

In a recent article on knowledge graphs and large language models (LLMs) in drug discovery, we noted that despite the transformative…

Dec 14, 2023

How retrieval-augmented generation (RAG) can transform drug discovery

Dec 14, 2023

BioStrand (a subsidiary of IPA)

BioStrand (a subsidiary of IPA)

Software and proprietary solutions for MULTI-omics data analysis. Effective research requires convenient and scalable tools.

Following

Help
Status
About
Careers
Press
Blog
Privacy
Terms
Text to speech
Teams